Celanese Corporation, a global chemical and specialty materials company, ]announced an investment in expanded capabilities to meet high global demand for pharmaceutical-grade polymers used in the development of implants and inserts for sustained-release drug delivery. The new 1,000-square-foot cleanroom facility, located in Edmonton, Alberta, will focus on cryogenic micronization of VitalDose® EVA material into a powder form that is ready to be blended with small molecules and biologics.
Celanese offers medical and pharmaceutical material solutions and expert development support to Pharmaceutical and Medical Device companies worldwide.
Last year, the company opened the Celanese Pharmaceutical Development & Feasibility Lab. The micronizer and clean room facility are being prepared to supply VitalDose® EVA in powder form by early 2023.